濮阳东方男科医院专不专业(濮阳东方医院治早泄价格不高) (今日更新中)

WASHINGTON, May 11 (Xinhua) -- Johns Hopkins University researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.The work, published Wednesday in the journal Science Translational Medicine, suggests that liver cells derived from so- called "induced-pluripotent stem cells (iPSCs)" could one day be used as an alternative to liver transplant in patients with serious liver diseases, bypassing long waiting lists for organs and concerns about immune system rejection of donated tissue."Our findings provide a foundation for producing functional liver cells for patients who suffer liver diseases and are in need of transplantation," says Yoon-Young Jang, assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center. "iPSC-derived liver cells not only can be generated in large amounts, but also can be tailored to each patient, preventing immune-rejection problems associated with liver transplants from unmatched donors or embryonic stem cells." A microsopic view shows human embryonic stem cells in various stages of differentiation into liver cells in this photo taken at Stanford University and released by the California Institute for Regenerative Medicine, March 9, 2009iPSCs are made from adult cells that have been genetically reprogrammed to revert to an embryonic stem cell-like state, with the ability to transform into different cell types. Human iPSCs can be generated from various tissues, including skin, blood and liver cells.Although the liver can regenerate in the body, end-stage liver failure caused by diseases like cirrhosis and cancers eventually destroy the liver's regenerative ability, Jang says. Currently, the only option for those patients is to receive a liver organ or liver cell transplant, a supply problem given the severe shortage of donor liver tissue for transplantation. In addition, mature liver cells and adult liver stem cells are difficult to isolate or grow in the laboratory, she says. By contrast, iPSCs can be made from a tiny amount of many kinds of tissue; and the embryonic stem- like iPSCs can grow in laboratory cultures indefinitely.For the study, Jang and colleagues generated human iPSCs from a variety of adult human cells, including liver cells, fibroblasts ( connective tissue cells), bone marrow stem cells and skin cells. They found that though the iPSCs overall were molecularly similar to each other and to embryonic stem cells, they retained a distinct molecular "signature" inherited from the cell of origin.

WASHINGTON, April 4 (Xinhua) -- Scientists have identified a gene that appears to play a role in regulating how much alcohol people drink, in a study of over 47,000 people published Monday in the Proceedings of the National Academy of Sciences.The researchers say that finding a common genetic variation influencing levels of alcohol consumption may lead to a better understanding of mechanisms underlying alcohol drinking behavior in the general population.The gene, called "autism susceptibility candidate 2", or AUTS2, has previously been linked to autism and attention deficit hyperactivity disorder, but its function is not known.The new study, by an international consortium led by scientists at Imperial College London and King's College London, found that there are two versions of the AUTS2 gene, one three times more common than the other. People with the less common version drink on average five percent less alcohol than people with the more common version.The gene is most active in parts of the brain associated with neuropsychological reward mechanisms, suggesting that it might play a part in regulating the positive reinforcement that people feel when they drink alcohol.Alcohol consumption is known to be partly determined by genes but until now the only gene known to make a notable contribution was the gene encoding alcohol dehydrogenase, an enzyme that breaks down alcohol in the liver.Professor Paul Elliott, from the School of Public Health at Imperial College London, said: "Of course there are a lot of factors that affect how much alcohol a person drinks, but we know from twin studies that genes play an important role. The difference that this particular gene makes is only small, but by finding it we've opened up a new area of research into the biological mechanisms that control drinking."

CANBERRA, April 1 (Xinhua) -- People who share bongs to smoke marijuana may be at risk of contracting pulmonary tuberculosis (TB) , Australian medical researchers warned on Friday.Dr Michael Hayes and Dr Susan Miles from Calvary Mater Hospital in Newcastle of Australia conducted the research, which centered on three recent TB cases in New South Wales.TB is caused by the bacteria Mycobacterium tuberculosis, which can be contracted by breathing in air droplets coughed from an infected person.The research suggested a link between active TB cases and shared bongs, which is the water pipes commonly used in marijuana smoking.According to Dr Hayes, the three young patients were regular or heavy cannabis users, and more recently there has been a fourth person in the region with similar characteristics had been diagnosed with TB.He said although the three initial cases were not related, there was concern about the high rate of positive contacts among people who had shared bongs with the active cases."Smoking marijuana is a cough-provoking activity and it is usually conducted in a confined environment that is conducive to the spread of the organism," he told Australia Associated Press.

BEIJING, Feb. 24 (Xinhua) -- Chinese Premier Wen Jiabao attended the opening ceremony of the China-EU Year of Youth in Beijing on Wednesday, encouraging young people from China and the EU to build a brighter future for bilateral strategic partnerships.Joining over 500 young people from China and the EU in the Capital Museum in downtown Beijing, Wen said that the year-long youth exchange campaign was the first theme year between China and the EU since the establishment of diplomatic ties, and is also the largest-ever China-EU cultural exchange program."This has revealed that our relations will be more vibrant in the future and full of hopes," he added.China and the EU are in a vital period for deepening cooperation, Wen said, calling on young people from both sides to consider and explore ways to share opportunities, meet challenges and seek common development, which has benefits for China, the EU and the world.Wen hopes that young people from both sides would always be brave in pursuing innovation and the truth. He also encouraged them to learn from each other in a frank and open spirit, in a bid to jointly create a better future for China-EU ties.A video speech from European Commission President Jose Manuel Barosso was aired at the ceremony. He said that the Year of Youth offers an interactive platform for European and Chinese young people to enhance mutual understanding and friendship and also inject vitality to China-EU relations.Premier Wen and Barroso jointly initiated The China-EU Year of Youth during the 12th EU-China summit held in 2009.Along with the opening ceremony in Beijing, Chinese and European youth were immersed in two-day discussions on topics such as culture, education, volunteering, creativity and environmental protection starting on Tuesday."We had excellent discussions on possible cooperation projects, ranging from environmental protection, world heritage to art and intellectual property," said Pierre Arlaud, a member of an EU youth delegation that arrived in Beijing on Monday to participate in the opening ceremony."I can feel there is a strong will from both sides to deepen understanding and forge a stronger partnership," he added.The opening ceremony was the first in a series of exchange activities that will be held throughout the year in China and Europe. The events include cultural seminars, volunteer service conferences, youth summer camps and TV debates.The year-long program was co-hosted by the All-China Youth Federation and the European Commission. The initiative aims to promote intercultural dialogue and strengthen mutual understanding and friendship between young people in China and the EU, as well as encouraging them to support the development of China-EU relations.

COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.

来源：资阳报